scholarly journals Corrigendum: Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study

2019 ◽  
Vol 10 ◽  
Author(s):  
Irene Lenoir-Wijnkoop ◽  
Dan Merenstein ◽  
Daria Korchagina ◽  
Christa Broholm ◽  
Mary Ellen Sanders ◽  
...  
Keyword(s):  
Health Care ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Health Care Cost ◽  
Economic Modeling ◽  
Societal Impact ◽  
Reduce Health Care Cost ◽  
The Usa ◽  
Tract Infections ◽  
Modeling Study

scholarly journals Incidence of respiratory tract infections and antibiotic use in primary health care

2016 ◽  
Vol 3 ◽  
pp. 332-335
Author(s):  
Małgorzata Pietrzykowska ◽  
Katarzyna Nowicka-Sauer ◽  
Piotr Gutknecht ◽  
Janusz Siebert
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Antibiotic Use ◽  
Primary Health ◽  
Tract Infections

scholarly journals Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care–Associated Infections in Australia: A Retrospective Case-cohort Study

2020 ◽  
Author(s):  
X J Lee ◽  
A J Stewardson ◽  
L J Worth ◽  
N Graves ◽  
T M Wozniak
Keyword(s):  
Health Care ◽  
Length Of Stay ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Hospital Admissions ◽  
Care Hospital ◽  
Retrospective Case ◽  
Health Care Associated Infections ◽  
Tract Infections ◽  
The Impact

Abstract Background Unbiased estimates of the health and economic impacts of health care–associated infections (HAIs) are scarce and focus largely on patients with bloodstream infections (BSIs). We sought to estimate the hospital length of stay (LOS), mortality rate, and costs of HAIs and the differential effects on patients with an antimicrobial-resistant infection. Methods We conducted a multisite, retrospective case-cohort of all acute-care hospital admissions with a positive culture of 1 of the 5 organisms of interest (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Enterococcus faecium) from 1 January 2012 through 30 December 2016. Data linkage was used to generate a data set of statewide hospital admissions and pathology data. Patients with bloodstream, urinary, or respiratory tract infections were included in the analysis and matched to a sample of uninfected patients. We used multistate survival models to generate LOS, and logistic regression to derive mortality estimates. Results We matched 20 390 cases to 75 635 uninfected control patients. The overall incidence of infections due to the 5 studied organisms was 116.9 cases per 100 000 patient days, with E. coli urinary tract infections (UTIs) contributing the largest proportion (51 cases per 100 000 patient days). The impact of a UTI on LOS was moderate across the 5 studied pathogens. Resistance significantly increased LOS for patients with third-generation cephalosporin-resistant K. pneumoniae BSIs (extra 4.6 days) and methicillin-resistant S. aureus BSIs (extra 2.9 days). Consequently, the health-care costs of these infections were higher, compared to corresponding drug-sensitive strains. Conclusions The health burden remains highest for BSIs; however, UTIs and respiratory tract infections contributed most to the health-care system expenditure.

Sign in / Sign up

Export Citation Format

Share Document